Urba, W J <br/><br/>
Anti-CD3 monoclonal antibody treatment of patients with CD3-negative tumors: a phase IA/B study.  [electronic resource] 

 -  Cancer research  May 1992 
 - 2394-401 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Differentiation, T-Lymphocyte--immunology<br/>CD3 Complex<br/>Cytokines--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Female<br/>Headache--etiology<br/>Humans<br/>Leukocyte Count<br/>Lymphocyte Activation<br/>Male<br/>Middle Aged<br/>Muromonab-CD3--metabolism<br/>Neoplasms--blood<br/>Receptors, Antigen, T-Cell--immunology<br/>Spinal Puncture